Worth reading
52Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
4180
Rights (4,180 underlying shares)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock compensation-type stock options (stock acquisition rights)
発行・処分する株式数
4,180 shares of common stock (4,180 stock acquisition rights, 1 share per right)
Intended allottee
Category Director who is an Audit and Supervisory Committee Member (including 1 Outside Director) / Number of Employees 1 person (1 Outside Director) / Number of stock acquisition rights 4,180 rights
No monetary payment is required in exchange for the stock acquisition rights.
Total issue value
No consideration
Amount of funds to be raised
Total amount to be paid: ¥0; estimated net proceeds: ¥0
Terms of the stock acquisition rights
Exercise price
No monetary payment or contribution of property other than money is required upon exercise. Adjustment provisions and adjustment floor: Not disclosed
Exercise period
From the allotment date of the stock acquisition rights (10 April 2026) until the date on which 10 years have elapsed, or the preceding business day if the final day is a non-business day
Number of Stock Acquisition Rights
Total number issued: 4,180 rights; outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
If a proposal concerning a corporate reorganization or similar transaction is approved at a General Meeting of Shareholders, or by resolution of the Board of Directors if a General Meeting of Shareholders resolution is not required, the Company may acquire the stock acquisition rights at no cost on a date separately determined by the Board of Directors.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
The holder must be a Director of the Company at the time of exercise. However, a person who was a Director may exercise the rights only in cases involving retirement or resignation, dismissal or termination (excluding disciplinary dismissal, etc.), death, disability or other legitimate reasons prescribed by the Board of Directors.
Categories and Number of Persons Covered
1 Director who is an Audit and Supervisory Committee Member (including 1 Outside Director) · 4,180 rights
Intended allottee's holding policy
The acquisition of the stock acquisition rights through transfer requires the approval of the Board of Directors.
Procedures under the Corporate Code of Conduct
Approved as equity compensation-type stock options by resolution of the 19th Annual General Meeting of Shareholders held on 25 March 2021. This matter was resolved by the Board of Directors.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock compensation-type stock options (stock acquisition rights) |
| Number of shares to be issued or disposed of | 4,180 shares of common stock (4,180 stock acquisition rights, 1 share per right) |
| Issue price and disposal price | No monetary payment is required in exchange for the stock acquisition rights. |
| Total issue value | No consideration |
| Amount of funds to be raised | Total amount to be paid: ¥0; estimated net proceeds: ¥0 |
| Intended allottee | Category Director who is an Audit and Supervisory Committee Member (including 1 Outside Director) / Number of Employees 1 person (1 Outside Director) / Number of stock acquisition rights 4,180 rights |
| Intended allottee's holding policy | The acquisition of the stock acquisition rights through transfer requires the approval of the Board of Directors. |
| Exercise price | No monetary payment or contribution of property other than money is required upon exercise. Adjustment provisions and adjustment floor: Not disclosed |
| Exercise period | From the allotment date of the stock acquisition rights (10 April 2026) until the date on which 10 years have elapsed, or the preceding business day if the final day is a non-business day |
| Number of Stock Acquisition Rights | Total number issued: 4,180 rights; outstanding unexercised rights: Not disclosed |
| Conditions for lifting transfer restrictions | The holder must be a Director of the Company at the time of exercise. However, a person who was a Director may exercise the rights only in cases involving retirement or resignation, dismissal or termination (excluding disciplinary dismissal, etc.), death, disability or other legitimate reasons prescribed by the Board of Directors. |
| Reason for acquisition without consideration | If a proposal concerning a corporate reorganization or similar transaction is approved at a General Meeting of Shareholders, or by resolution of the Board of Directors if a General Meeting of Shareholders resolution is not required, the Company may acquire the stock acquisition rights at no cost on a date separately determined by the Board of Directors. |
| Categories and Number of Persons Covered | 1 Director who is an Audit and Supervisory Committee Member (including 1 Outside Director) · 4,180 rights |
| Procedures under the Corporate Code of Conduct | Approved as equity compensation-type stock options by resolution of the 19th Annual General Meeting of Shareholders held on 25 March 2021. This matter was resolved by the Board of Directors. |
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.These stock compensation-type stock options will be issued as remuneration for the Company's Directors, as approved at the 19th Annual General Meeting of Shareholders held on 25 March 2021.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.